Health and Healthcare

Amgen : AMGN

All Amgen Articles

707 Articles

Chris Lange | Oct 12, 2020 at 10:03 AM EDT

Short Sellers Need to Find a Clue on Major Biotechs

The September 30 short interest data has been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Oct 9, 2020 at 12:20 PM EDT

4 Very Profitable Biotech Stocks Expected to Soar Into 2021

24/7 Wall St. has been reviewing many sectors for leadership heading into earnings. One area that can offer some defensive…

Jon C. Ogg | Oct 9, 2020 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Amazon, Amgen, Chevron, Exxon, GE, IBM, Marvell, Rocket, 3D Systems, Zoom and More

Friday's top analyst upgrades and downgrades included AMD, Amazon.com, Amgen, Chevron, Exxon Mobile, General Electric, IBM, Lowe's Companies, Marvell Technology,…

Chris Lange | Sep 25, 2020 at 9:54 AM EDT

Biotech Short Sellers Hike Their Bets

The September 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 24, 2020 at 3:36 PM EDT

Why Amgen Is Called to Outperform Large-Cap Biotechs

Credit Suisse has set an Outperform rating and $290 price target on Amgen shares. That target implies more than 20%…

Chris Lange | Sep 19, 2020 at 9:26 AM EDT

This Week in Coronavirus News

As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple…

Jon C. Ogg | Sep 12, 2020 at 10:01 AM EDT

How the Dow Can Still Rise Above 30,000 Before 2021

Here is how the Dow Jones industrial average can still continue to rise and hit the 30,000 mark by year's…

Chris Lange | Sep 11, 2020 at 10:05 AM EDT

Short Sellers Hike Their Bets in Major Biotechs

The August 31 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 26, 2020 at 10:13 AM EDT

Major Biotechs Scare Off Short Sellers

The August 14 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Aug 24, 2020 at 6:25 PM EDT

New DJIA Index Changes Going From America 1.0 to America 3.0 With Biotech and Tech

The Dow Jones industrial average changes look a bit strange, and the real effort behind those changes may simply be…

Chris Lange | Aug 12, 2020 at 8:25 AM EDT

Short Sellers Shy Away From Big Biotech

The July 31 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Jul 29, 2020 at 9:11 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More

Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate Technology,…

Chris Lange | Jul 27, 2020 at 9:41 AM EDT

Big Biotechs Scare Off Short Sellers

The July 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 26, 2020 at 6:31 AM EDT

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players…

Chris Lange | Jul 24, 2020 at 10:51 AM EDT

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm…

1 … 8 9 10 11 12 … 48

Amgen : AMGN

All Amgen Articles

Short Sellers Need to Find a Clue on Major Biotechs

4 Very Profitable Biotech Stocks Expected to Soar Into 2021

Top Analyst Upgrades and Downgrades: AMD, Amazon, Amgen, Chevron, Exxon, GE, IBM, Marvell, Rocket, 3D Systems, Zoom and More

Biotech Short Sellers Hike Their Bets

Why Amgen Is Called to Outperform Large-Cap Biotechs

This Week in Coronavirus News

How the Dow Can Still Rise Above 30,000 Before 2021

Short Sellers Hike Their Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

New DJIA Index Changes Going From America 1.0 to America 3.0 With Biotech and Tech

Short Sellers Shy Away From Big Biotech

Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More

Big Biotechs Scare Off Short Sellers

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Millions of 401(k) Holders Were Forced to Buy SpaceX at $160. They’ve Already Lost More Than $1 Billion.

Trump Promised He’d Reduce Electricity Prices By 50% In 18 Months. We Ran The Numbers.

Does Your Pension Count Toward the 15% Retirement Rule? Dave Ramsey Breaks Down the Math

Does Your Pension Count Toward the 15% Retirement Rule? Dave Ramsey Breaks Down the Math

He Was Pushed Out at 63 in an AI Restructuring. Why This Couple Is Claiming His Wife's Smaller Check First, Not His.

Millions of 401(k) Holders Were Forced to Buy SpaceX at $160. They’ve Already Lost More Than $1 Billion.

Trump Promised He’d Reduce Electricity Prices By 50% In 18 Months. We Ran The Numbers.

Amgen : AMGN

All Amgen Articles

Short Sellers Need to Find a Clue on Major Biotechs

4 Very Profitable Biotech Stocks Expected to Soar Into 2021

Top Analyst Upgrades and Downgrades: AMD, Amazon, Amgen, Chevron, Exxon, GE, IBM, Marvell, Rocket, 3D Systems, Zoom and More

Biotech Short Sellers Hike Their Bets

Why Amgen Is Called to Outperform Large-Cap Biotechs

This Week in Coronavirus News

How the Dow Can Still Rise Above 30,000 Before 2021

Short Sellers Hike Their Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

New DJIA Index Changes Going From America 1.0 to America 3.0 With Biotech and Tech

Short Sellers Shy Away From Big Biotech

Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More

Big Biotechs Scare Off Short Sellers

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Millions of 401(k) Holders Were Forced to Buy SpaceX at $160. They’ve Already Lost More Than $1 Billion.

Trump Promised He’d Reduce Electricity Prices By 50% In 18 Months. We Ran The Numbers.

Does Your Pension Count Toward the 15% Retirement Rule? Dave Ramsey Breaks Down the Math

Featured Reads

Does Your Pension Count Toward the 15% Retirement Rule? Dave Ramsey Breaks Down the Math

He Was Pushed Out at 63 in an AI Restructuring. Why This Couple Is Claiming His Wife's Smaller Check First, Not His.